Sigma Planning Corp’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Sigma Planning Corp’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16,643	Closed	-$296K	–	1015
2018 Q3	$296K	Buy	16,643 +5,993	+56%	+$103K	0.02%	694
2018 Q2	$147K	Buy	+10,650	New	+$126K	0.01%	853

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Sigma Planning Corp's ECYT Position: Q4 2018 in Review

Sigma Planning Corp sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 16,643 shares — an estimated $296K sold.

Sigma Planning Corp first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $296K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Sigma Planning Corp reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Sigma Planning Corp sold 16,643 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $296K.
Sigma Planning Corp first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Sigma Planning Corp's Endocyte, Inc. Common Stock position peaked at $296K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Sigma Planning Corp's 13F filing for Q4 2018, filed 31 Jan 2019.